Experience

World Health Organization Office at the EU

• Belgium
• International Affairs
• 1 - 100 Employee

• Consultant, Health Economist

  • Dec 2020 - Present

  Consultant at the WHO Barcelona Office for Health Systems Financing (WHO Europe) • Preparing health financing, financial protection and UHC databases to construct the UHC policy watch, an online platform providing comprehensive country-level and comparative information on FP and coverage policy in all 53 Member States. • Collating and analyzing qualitative and quantitative information on coverage policy, preparing it for dissemination via UHC Policy Watch and finding ways to present this information in a systematic and user-friendly way • Producing statistical quantitative analysis of household budget survey micro data using advanced statistical methods and statistical software (STATA) to advise EU countries on optimising health policies and achieving UHC •Supporting national experts with statistical and policy analysis, updating country-level analysis, editing country reports on Financial Protection and disseminating the results of FP analysis • Producing briefs on the contribution of health systems to the wider economy in countries of the European Union and selected non-EU countries in collaboration with the European Observatory on Health Systems and Policies (OBS) to support dialogue between health and finance ministries



World Health Organization

• Switzerland
• International Affairs
• 700 & Above Employee

• Consultant, Health Economist

  • Jan 2020 - Dec 2020

  Consultant at the WHO Western Pacific Regional Office (WPRO) •Developed structured high-profile case study reports on the COVID-19 response and UHC in four selected WPRO countries with a relevant research topic provided by WHO. •Prepared health financing, COVID-19 and UHC dashboards for 49 ADB countries to be published on WPRO’s website and presented at the joint Health and Finance Ministers’ meeting organised by WHO and ADB in September 2020. •Quantified the economic returns of healthy ageing in the Western Pacific Region by developing country-specific empirical reports. Findings have been published and presented at the Japan regional action plan for ageing in October 2020. •Economic and Health Financing Implications of Population Ageing in the Western Pacific Region publication date: Dec 9, 2020 publication description: WHO Regional Office for Europe UN City, Marmorvej 51 DK-2100 Copenhagen Ø, Denmark Globally, decision-makers are concerned that population ageing will result in slower economic growth and therefore greater demands for health and social care. However, a new set of six country studies by the European Observatory for Health Systems and Policies, WHO Western Pacific Regional Office, and WKC, shows how country investments in healthy ageing could positively affect economic growth across a range of country settings (Australia, Japan, Korea, Mongolia, New Zealand and Viet Nam) in the Western Pacific Region with over a third of the world's population 65 years and older. Investments in healthy ageing can health countries realize the full potential of its older population and contribute to economic growth. Read the 6 case studies here: https://extranet.who.int/kobe_centre/en/project-details/EURO



Utrecht Centre for Pharmaceutical Policy and Regulation

• Netherlands
• Non-profit Organization Management
• 1 - 100 Employee

• Consultant, Researcher

  • Sep 2019 - Jan 2020

  •Updated a series of ten systematic literature reviews synthesizing quantitative evidence of the effectiveness of country pharmaceutical pricing policies in accordance with the WHO guidelines • Advised a wider network of consultants on the interpretation of findings and risk of bias assessment of quasi-experimental study designs, such as the difference-in-difference • Read and extracted data from robust study designs, including controlled before-after, difference-in-difference, panel and regressions, interrupted time series and repeated measures analyses • Assisted project managers in the construction of the data extraction sheet, ensuring that it fits the WHO protocol as well as the different eligible study designs • Supported researchers in producing summary of findings and risk of bias assessment tables, following the GRADE methodology to evaluate the overall strength, direction and quality of the evidence • Aided researchers in finalizing the grey literature search • Contributed to the writing of the final report ‘WHO Guideline on Country Pharmaceutical Pricing Policies’ published in 2021 (see attached) •The full study protocol is published: Tordrup D, van den Ham HA, Glanville J, Mantel-Teeuwisse AK. Systematic reviews of ten pharmaceutical pricing policies - a research protocol. J Pharm Policy Pract. 2020 Jul 16;13:22. doi: 10.1186/s40545-020-00228-0



World Health Organization Office at the EU

• Belgium
• International Affairs
• 1 - 100 Employee

• Analyst, Policy Researcher

  • Jun 2019 - Sep 2019

  European Observatory on Health Systems and Policies - London Hub Conducted the Health and the wider economy country report on Belgium. European Observatory on Health Systems and Policies - London Hub Conducted the Health and the wider economy country report on Belgium.



KPMG

• Canada
• Accounting
• 700 & Above Employee

• Internship Trainee

  • Jun 2017 - Jul 2017



Integrated Pharma Solutions (IPS)

• Lebanon
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Internship Trainee

  • Jul 2016 - Aug 2016



Lebanon By Net

• Lebanon

• Internship Trainee

  • Dec 2015 - Jan 2016